Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands)
- 1 August 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 16 (6), 675-681
- https://doi.org/10.1007/s10552-005-1227-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian womenCancer Letters, 2002
- Quality and Quantity of DNA Isolated from Frozen Urine in Population-Based ResearchAnalytical Biochemistry, 2002
- Smoking and Breast Cancer: A Meta-AnalysisReviews on Environmental Health, 2001
- Simultaneous Determination of Polymorphism in N-Acetyltransferase 1 and 2 Genes by Reverse Line Blot HybridizationAnalytical Biochemistry, 2000
- Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotypePharmacogenetics, 2000
- Genotyping Human Arylamine N-Acetyltransferase Type 1 (NAT1): The Identification of Two Novel Allelic VariantsBiochemical Pharmacology, 1998
- Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutationsPharmacogenetics, 1998
- Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksPharmacogenetics, 1996
- Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.Proceedings of the National Academy of Sciences, 1988
- The dom project for the early detection of breast cancer, Utrecht, The NetherlandsJournal of Chronic Diseases, 1984